Bestic patent granted in China
The State Intellectual Property Office in China informs that they have granted patent for the assistive eating device Bestic®. The patent protects Camanio Care on one of the world’s most essential markets for welfare technology.
According to the EU-project ”SILVER” (www.silverpcp.eu), around 0.2% of the adult population is being fed. This is equal to approximately 3 million individuals in China alone. The reasons behind eating difficulties are several. However, neurological diagnosis such as stroke, ALS, Parkinson and spinal cord lesion can cause eating difficulties. People suffering from eating difficulties are also more likely to develop undernutrition, which is a big problem in today’s society.
Assistive eating device Bestic®
Granted patent gives higher protection
The patent that has been granted is the company’s main patent for Bestic. The term of the patent is ten years. Bestic is an assistive eating device which uses a spoon to lift the food from the plate up to the mouth.
- With this patent protection set up in China we feel safe in our patent strategy where we prioritize the markets with the highest potential. We now have the possibility to meet the big interest regarding Bestic, both on the Chinese market and on the Asian market as a whole, says Catharina Borgenstierna, CEO Camanio Care AB.
For further information, please contact:
Catharina Borgenstierna, CEO
Telephone: 0733-93 00 07
About Camanio Care
Camanio Care is a care tech company, developing services with the individual in focus. The company offers solutions within robotics, assistive devices, and gamification, with products such as BikeAround™, Bestic®, and Giraff™. Through three focus areas; Active Life, Mealtime and Digital Care, the company wishes to support people’s basic needs and increase the competence and quality within health care.
Camanio Care has its headquarters in Stockholm, Sweden, a subsidiary in the U.S., as well as distributors in China, Australia and ten European countries. Subscribe to our newsletter and/or read more about us, Camanio Care at: www.camanio.com.
Find us on the following channels:
This information is information that Camanio Care is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of the contact persons set out above, on April 18th, 2018.